Effects of Transfer Energy Capacitive and Resistive On Musculoskeletal Pain: A Systematic Review and Meta-Analysis

Authors

  • Soroush Sadri Department of Physical Medicine and Rehabilitation, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
  • Babak Vahdatpour Department of Physical Medicine and Rehabilitation, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
  • Shila Haghighat Department of Physical Medicine and Rehabilitation, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
  • Leyli Sadri Department of Pediatric Dentistry, School of Dentistry, Mazandaran University of Medical Sciences, Mazandaran, Iran
  • Mehdi Taghian Department of Oral and Maxillofacial Surgery, School of Dentistry, Mazandaran University of Medical Sciences, Mazandaran, Iran

DOI:

https://doi.org/10.31661/gmj.v11i.2407

Keywords:

Musculoskeletal, Pain, ransfer Energy Capacitive

Abstract

The use of transfer energy capacitive and resistive (TECAR) therapy to treat musculoskeletal pain has not been clearly established. Hence, this study was conducted to combine the available results. We searched the main databases, including PubMed (January 1950), Web of Knowledge (January 1945), Scopus (January 1980), and ProQuest (January 1983) until December 2021, to find the related studies. Only those studies were included that assessed the pain in participants who received TECAR therapy and compared it with a control group. Using the random effect model, standardized mean difference (SMD) was calculated at a 95% confidence interval (CI). The differences between patients and control group were -1.04 after four weeks of intervention (95% CI: -1.59 to -0.48, I2=86.9%) and -1.80 after eight weeks (95% CI: -2.15 to -1.46, I2=87%), which was significant (P<0.001). The intra-group pain comparison before and after two, four, and eight weeks of TECAR therapy obtained SMD levels of -3.96 (95% CI: -5.28 to -2.65, I2=96.9%), -4.12 (95% CI: -5.98 to -2.26, I2=97.3), and -5.03 (95% CI: -7.23 to -2.83, I2=92.2%), respectively. Despite some limitations, our findings may assist clinicians in decision-making about TECAR therapy for the approach to musculoskeletal pain based on evidence-based medicine.

References

Iqbal ZA, Alghadir AH. Cumulative trauma disorders: A review. J Back Musculoskelet Rehabil. 2017;30(4):663-6. https://doi.org/10.3233/BMR-150266PMid:28453448 Pacheco-Carroza EA. Visceral pain, mechanisms, and implications in musculoskeletal clinical practice. Med Hypotheses. 2021;153:110624. https://doi.org/10.1016/j.mehy.2021.110624PMid:34126503 Babatunde OO, Jordan JL, Van der Windt DA, Hill JC, Foster NE, Protheroe J. Effective treatment options for musculoskeletal pain in primary care: A systematic overview of current evidence. PloS one. 2017;12(6):e0178621. https://doi.org/10.1371/journal.pone.0178621PMid:28640822 PMCid:PMC5480856 Vincent R. Tecar therapy at the time of evidence-based practice: A scoping review. Kinesitherapie. 2020;20(221):10-9. doi:10.1016/j.kine.2020.03.004. https://doi.org/10.1016/j.kine.2020.03.004 Cameron MH. Physical agents in rehabilitation: from research to practice. 4th ed. Elsevier Health Sciences; 2012. Yokota Y, Sonoda T, Tashiro Y, Suzuki Y, Kajiwara Y, Zeidan H et al. Effect of Capacitive and Resistive electric transfer on changes in muscle flexibility and lumbopelvic alignment after fatiguing exercise. J Phys Ther Sci. 2018;30(5):719-25. https://doi.org/10.1589/jpts.30.719PMid:29765189 PMCid:PMC5940481 Niajalili M, Sedaghat M, Reazasoltani A, Akbarzade Baghban AR, Naimi SS. Effect of Capacitive Tecar Therapy on Foot Pain and Tactile Sensation in Patients with Type 2 Diabetes. Arch Phys Med Rehabil. 2020;21(3):304-19. https://doi.org/10.32598/RJ.21.3.60.5 Notarnicola A, Maccagnano G, Gallone M, Covelli I, Tafuri S, Moretti B. Short term efficacy of capacitive-resistive diathermy therapy in patients with low back pain: a prospective randomized controlled trial. J Biol Regul Homeost Agents. 2017;31(2):509-15. Terranova A, Vermiglio G, Arena S, Cicciò A, Di Dio S, Vermiglio M. Tecarterapia nel trattamento post-chirurgico delle fratture di femore. Eur J Phys Rehabil Med. 2008;44(3):1-2. Tranquilli C, Ganzit G, Ciufetti A, Bergamo P, Combi F, Italian Football Federation. Multicenter Study on TECAR® Therapy in Sports Pathologies. Southampton: Tecar UK; 2009. Hawamdeh M. The effectiveness of capacitive resistive diathermy (Tecartherapy®) in acute and chronic musculoskeletal lesions and pathologies. Eur J Sci Res. 2014;118(3):336-40. Ribeiro S, Henriques B, Cardoso R. The Effectiveness of TECAR Therapy in Musculoskeletal Disorders. International Journal of Public Health and Health Systems. 2018;3(5):77-83. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;17(1):1-12. https://doi.org/10.1016/0197-2456(95)00134-4 Berger VW, Alperson SY. A general framework for the evaluation of clinical trial quality. Rev Recent Clin Trials. 2009;4(2):79-88. https://doi.org/10.2174/157488709788186021PMid:19463104 PMCid:PMC2694951 Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557-60. https://doi.org/10.1136/bmj.327.7414.557PMid:12958120 PMCid:PMC192859 Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539-58. https://doi.org/10.1002/sim.1186PMid:12111919 Higgins J, Thomas J, Chandler J, Cumpston M, Li T, Page M et al. Cochrane Handbook for Systematic Reviews of Interventions version 6.3. Cochrane; 2022. Available from: www.training.cochrane.org/handbook. DerSimonian R, Laird NJCct. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177-88. https://doi.org/10.1016/0197-2456(86)90046-2 Rodríguez-Sanz J, López-de-Celis C, Hidalgo-García C, Canet-Vintró M, Fanlo-Mazas P, Pérez-Bellmunt A. Are the effects in temperature and current flow dependent on the areas of electrode application of capacitive-resistive electric transfer on the shoulder? A cadaveric study. BMC Musculoskelet Disord. 2020. https://doi.org/10.21203/rs.3.rs-103518/v1 Rodríguez-Sanz J, Pérez-Bellmunt A, López-de-Celis C, Lucha-López OM, González-Rueda V, Tricás-Moreno JM et al. Thermal and non-thermal effects of capacitive-resistive electric transfer application on different structures of the knee: A cadaveric study. Sci Rep. 2020;10(1):1-9. https://doi.org/10.1038/s41598-020-78612-8PMid:33339869 PMCid:PMC7749154 Paolucci T, Pezzi L, Centra M, Porreca A, Barbato C, Bellomo R et al. Effects of capacitive and resistive electric transfer therapy in patients with painful shoulder impingement syndrome: a comparative study. J Int Med Res. 2020;48(2):0300060519883090. https://doi.org/10.1177/0300060519883090PMid:31680597 PMCid:PMC7783264 Osti R, Pari C, Salvatori G, Massari LJLims. Tri-length laser therapy associated to tecar therapy in the treatment of low-back pain in adults: a preliminary report of a prospective case series. Lasers Med Sci. 2015;30(1):407-12. https://doi.org/10.1007/s10103-014-1684-3PMid:25376670 Coccetta CA, Sale P, Ferrara PE, Specchia A, Maccauro G, Ferriero G et al. Effects of capacitive and resistive electric transfer therapy in patients with knee osteoarthritis: a randomized controlled trial. Int J Rehabil Res. 2019;42(2):106-11. https://doi.org/10.1097/MRR.0000000000000324PMid:30362981 Davari A, Mansour Sohani S, Sarrafzadeh J, Nikjoui A. Evaluation of the Effects of Tecar Therapy on Acute Symptoms of Athletes Following Lateral Ankle Ligament Sprain. Func Disabil J. 2021;4(1):31. https://doi.org/10.32598/fdj.4.31 Ganzit G, Stefanini L, Stesina G. Tecar® Therapy in the treatment of acute and chronic pathologies in sports. FMSE (Italian Sports Medicine Federation) - CONI Institute of Sports of Medicine, Torino; 2000. Kim G-W, Won YH, Park S-H, Seo J-H, Kim D-h, Lee HN et al. Effects of a newly developed therapeutic deep heating device using high frequency in patients with shoulder pain and disability: a pilot study. Pain Res Manag. 2019;2019:8215371. https://doi.org/10.1155/2019/8215371PMid:31191789 PMCid:PMC6525801 Costantino C, Pogliacomi F, Vaienti E. Cryoultrasound therapy and tendonitis in athletes: a comparative evaluation versus laser CO2 and t.e.ca.r. therapy. Acta Biomed. 2005;76(1):37-41. Stagi P, Paoloni M, Ioppolo F, Palmerini V, Santilli V. Studio clinico randomizzato in doppio cieco tecarterapia versus placebo nel trattamento della lombalgia. Eur Med Phys. 2008;44:1-3. Orlandini D, Cavallari G, Amoresano A. Phantom limb pain: treatment with tecar® therapy and tens. Italy: INAIL Prosthetic Centre Vigorso di Budrio (Bologna); 2003.

Published

2022-11-15

Issue

Section

Review Article